BRT partners with SenzaGen on in vitro GARD® test platform

BRT and SenzaGen

Burleson Research Technologies has partnered with SenzaGen in an agreement to market and offer the in vitro GARD™ test method in the United States, making BRT the first U.S. laboratory to offer this service. The GARD™ method displays a higher accuracy than other available methods and reveals if chemical substances are causing allergies in humans.